Targeting Oncogenic KRAS in Pancreatic Cancer

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 102卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：569 / 569
页数：1
相关论文
共 50 条
  • [41] RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
    R Kang
    W Hou
    Q Zhang
    R Chen
    Y J Lee
    D L Bartlett
    M T Lotze
    D Tang
    H J Zeh
    Cell Death & Disease, 2014, 5 : e1480 - e1480
  • [42] Oncogenic Kras drives cancer-associated fibroblast heterogeneity and substate changes in pancreatic cancer
    Thalappillil, Jennifer S.
    Caligiuri, Giuseppina
    Nadella, Sandeep
    Alagesan, Brinda
    Yordanov, Georgi N.
    Shakiba, Mojdeh
    Kaminow, Benjamin
    Hinds, Juliene
    Perez-Mancera, Pedro A.
    Preall, Jonathan
    Dobin, Alexander
    Park, Youngkyu
    Tuveson, David A.
    CANCER RESEARCH, 2022, 82 (12)
  • [43] RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer
    Azizan, Nancy
    Suter, Melissa A.
    Liu, Yan
    Logsdon, Craig D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 592 - 597
  • [44] A pyrrole-Imidazole polyamide conjugate targeting KRAS oncogenic mutations is a promising approach against KRAS mutated colorectal and pancreatic cancers
    Nagase, Hiroki
    Takatori, Atsushi
    Watanabe, Takayoshi
    Koshikawa, Nobuko
    Lin, Jason
    CANCER RESEARCH, 2017, 77
  • [45] Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
    Kapoor, Avnish
    Yao, Wantong
    Ying, Haoqiang
    Hua, Sujun
    Liewen, Alison
    Sadanandam, Anguraj
    Al-Khalil, Ramsey
    Viale, Andrea
    Pettazzoni, Piergiorgio
    Sanchez, Nora
    Protopopov, Alexei
    Zhang, Jianhua
    Heffernan, Timothy
    Johnson, Randy L.
    Chin, Lynda
    Wang, Y. Alan
    Draetta, Giulio
    DePinho, Ronald A.
    CANCER RESEARCH, 2015, 75
  • [46] Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
    Sivakumar, Shivan
    de Santiago, Ines
    Chlon, Leon
    Markowetz, Florian
    PLOS MEDICINE, 2017, 14 (01)
  • [47] Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
    Kapoor, Avnish
    Yao, Wantong
    Ying, Haoqiang
    Hua, Sujun
    Liewen, Alison
    Wang, Qiuyun
    Zhong, Yi
    Wu, Chang-Jiun
    Sadanandam, Anguraj
    Hu, Baoli
    Chang, Qing
    Chu, Gerald
    Al-Khalil, Ramsey
    Jiang, Shan
    Xia, Hongai
    Fletcher-Sananikone, Eliot
    Lim, Carol
    Horwitz, Gillian
    Viale, Andrea
    Pettazzoni, Piergiorgio
    Sanchez, Nora
    Wang, Huamin
    Protopopov, Alexei
    Zhang, Jianhua
    Heffernan, Timothy
    Johnson, Randy
    Chin, Lynda
    Wang, Alan
    Draetta, Giulio
    DePinho, Ronald
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [48] Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
    Kapoor, Avnish
    Yao, Wantong
    Ying, Haoqiang
    Hua, Sujun
    Liewen, Alison
    Wang, Qiuyun
    Zhong, Yi
    Wu, Chang-Jiun
    Sadanandam, Anguraj
    Hu, Baoli
    Chang, Qing
    Chu, Gerald C.
    Al-Khalil, Ramsey
    Jiang, Shan
    Xia, Hongai
    Fletcher-Sananikone, Eliot
    Lim, Carol
    Horwitz, Gillian I.
    Viale, Andrea
    Pettazzoni, Piergiorgio
    Sanchez, Nora
    Wang, Huamin
    Protopopov, Alexei
    Zhang, Jianhua
    Heffernan, Timothy
    Johnson, Randy L.
    Chin, Lynda
    Wang, Y. Alan
    Draetta, Giulio
    DePinho, Ronald A.
    CELL, 2014, 158 (01) : 185 - 197
  • [49] Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
    Luo, Yongde
    Li, Xiaokun
    Ma, Jianjia
    Abbruzzese, James L.
    Lu, Weiqin
    CANCERS, 2021, 13 (04) : 1 - 19
  • [50] Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras
    Carriere, Catherine
    Young, Alison L.
    Gunn, Jason R.
    Longnecker, Daniel S.
    Korc, Murray
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 382 (03) : 561 - 565
12345